EP-009

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEP-009

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionTyrosine-protein kinase JAK3 inhibitors

TargetsTyrosine-protein kinase JAK3

Therapy Area/IndicationsLymphomaLeukemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesEp Pharma

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesEp Pharma

Active IndicationsN/A

Inactive IndicationsLymphomaLeukemia

ATC CodeN/A